** Shares of Australia's Medical Developments International MVP.AX rise as much as 35.1% to A$0.52, their highest level since January 22
** On track to log its steepest intraday pct rise since April 29, 2025
** The pharmaceuticals company posts third quarter revenue of A$10.5 million ($7.48 million), up A$1.6 million on pcp
** About 803,000 shares change hands, 7.8 times the 30-day avg
** Down 12.6% YTD, including the session's moves
($1 = 1.4041 Australian dollars)
(Reporting by Anjali Singh in Bengaluru)
((anjali.singh2@thomsonreuters.com; ))